版本:
中国

BRIEF-Biostage says provides regulatory update of Cellspan Esophageal Implant

Oct 6 Biostage Inc

* Biostage management has determined that it will extend duration of ongoing GLP animal studies

* Biostage provides regulatory update of Cellspan Esophageal Implant

* Expects to file its ind application with FDA by end of Q2 of 2017

* FDA requested that company extend its pre-clinical large-animal safety study for its Cellspan Esophageal Implant Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐